Risk of contralateral second primary breast cancer according to hormone receptor status in Germany-Reference-Cited by-同舟云学术

Risk of contralateral second primary breast cancer according to hormone receptor status in Germany

Published:2014-10 Issue:5 Volume:16 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Rusner Carsten,Wolf Katharina,Bandemer-Greulich Ulrike,Engel Jutta,Stegmaier Christa,Holleczek Bernd,Schubert-Fritschle Gabriele,Tillack Anett,Stang Andreas

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-014-0452-4.pdf

Reference32 articles.

1. Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G: Breast cancer. Lancet. 2005, 365: 1727-1741. 10.1016/S0140-6736(05)66546-4.

2. Chen Y, Thompson W, Semenciw R, Mao Y: Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev. 1999, 8: 855-861.

3. Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M, Reiner AS, Riedel ER, Thomas DC, Mellemkjaer L, Lynch CF, Boice JD, Anton-Culver H, Bernstein JL: Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol. 2010, 28: 2404-2410. 10.1200/JCO.2009.24.2495.

4. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 1998, 351: 1451-1467. 10.1016/S0140-6736(97)11423-4.

5. Li CI, Malone KE, Weiss NS, Daling JR: Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst. 2001, 93: 1008-1013. 10.1093/jnci/93.13.1008.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second primary malignancies: A clinicopathological study from a tertiary care centre;Journal of Clinical and Scientific Research;2024-01

2. Differential Second Primary Malignancy Occurrence After Breast Cancer According to HER2 Status: A Population-Based Study;International Journal of General Medicine;2021-11

3. Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status;Cancer;2021-05-18

4. Adipose-derived regenerative cells and lipotransfer in alleviating breast cancer-related lymphedema: An open-label phase I trial with 4 years of follow-up;Stem Cells Translational Medicine;2021-02-17

5. Clinical characteristics and the associated risk factors of the development of bilateral breast cancers: A case-control study;Annals of Medicine and Surgery;2020-12